PEARL PHARMACY LIMITED

PEARL PHARMACY LIMITED
Statement of Financial Position
As at 29 April 2025

	Notes	2025 £	2024 £
Fixed assets
Intangible fixed assets	3	198,386	198,386
Tangible fixed assets	4	6,918	8,436
Investments	5	0	205,000
		205,304	411,822
Current assets
Stocks		34,500	58,000
Debtors		1,807,838	1,705,984
Cash at bank and in hand		156,513	94,981
		1,998,851	1,858,965
Creditors: amount falling due within one year		(994,848)	(1,079,013)
Net current assets		1,004,003	779,952

Total assets less current liabilities		1,209,307	1,191,774
Creditors: amount falling due after more than one year		(381,050)	(436,035)
Net assets		828,257	755,739

Capital and reserves
Called up share capital	6	100	100
Profit and loss account		828,157	755,639
Shareholders' funds		828,257	755,739

For the period ended 29 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved by the director on 29 April 2026 and were signed by:

-------------------------------
Sheraz Ahmed Qureshi
Director

PEARL PHARMACY LIMITED
Notes to the Abridged Financial Statements
For the Period 01 May 2024 to 29 April 2025

General Information

PEARL PHARMACY LIMITED is a private company, limited by shares, registered in England and Wales, registration number 06424453, registration address 617 Washwood Heath Road, Ward End, Birmingham, B8 2HB.

The presentation currency is £ sterling.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.

The financial statements are prepared in sterling which is the functional currency of the company.

Turnover

Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

Taxation

Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted

Tangible fixed assets

Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:

Plant and Machinery

18 % Reducing Balance

Fixed asset investments

Fixed asset investments are stated at cost less provision for any permanent diminution in value.

Stocks

Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.

2.	Average number of employees Average number of employees during the period was 12 (2024 : 12).

Intangible fixed assets

Cost	Other	Total
	£	£
At 01 May 2024	198,386	198,386
Additions	-	-
Disposals	-	-
At 29 April 2025	198,386	198,386
Net book values
At 29 April 2025	198,386	198,386
At 30 April 2024	198,386	198,386

Tangible fixed assets

Cost or valuation	Plant and Machinery	Total
	£	£
At 01 May 2024	111,698	111,698
Additions	-	-
Disposals	-	-
At 29 April 2025	111,698	111,698
Depreciation
At 01 May 2024	103,262	103,262
Charge for period	1,518	1,518
On disposals	-	-
At 29 April 2025	104,780	104,780
Net book values
Closing balance as at 29 April 2025	6,918	6,918
Opening balance as at 01 May 2024	8,436	8,436

Investments

Cost	Other investments other than loans	Total
	£	£
At 01 May 2024	205,000	205,000
Additions	-	-
Disposals	-	-
Revaluations	(205,000)	(205,000)
At 29 April 2025	-	-

Share Capital

Allotted, called up and fully paid	2025 £		2024 £
100 Class A shares of £1.00 each	100		100
	100		100

Registered Number: 06424453
England and Wales
PEARL PHARMACY LIMITED

Abridged Accounts

Period of accounts Start date: 01 May 2024 End date: 29 April 2025